TRACHITOL

This brand name is authorized in Estonia, Malta, Netherlands.

Active ingredients

The drug TRACHITOL contains a combination of these active pharmaceutical ingredients (APIs):

1	Lidocaine UNII 98PI200987 - LIDOCAINE
	Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.
	Read more about Lidocaine
2	Propyl parahydroxybenzoate UNII Z8IX2SC1OH - PROPYLPARABEN
	Read more about Propyl hydroxybenzoate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R02AD	Anesthetics, local	R Respiratory system → R02 Throat preparations → R02A Throat preparations
Discover more medicines within R02AD

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1031410
MT	Medicines Authority	MA048/00202
NL	Z-Index G-Standaard, PRK	90948